…there’s a long way to go before these therapies are available to everyone. For one, many of the substances, including MDMA and psilocybin, will likely not get the legal green light for another few years, though some jurisdictions are leading the way. With one in five North Americans experiencing a mental illness in any given…
Mother’s Therapy doesn’t present de Lattre’s mother’s experience as a model to emulate. Instead, the photographer feels it should be viewed as both a visual account of how people react to despair, and as a testimony to how much a mother wanted her life back. His mother has recently cut ties with her former psychiatrist to…
…lawyer pushed against extending protections for members of the family, which is worth billions: Joe Rice, a lead lawyer for local governments who had sued Purdue… Judge Robert Drain said that if a deal was not in place by [Feb. 17, 2022], “all bets are open” as to whether he would protect the family again.…
The lawsuit was filed against the DEA by three Seattle-based patients… The U.S. Court of Appeals for the Ninth Circuit has dismissed a lawsuit by cancer patients seeking to use psilocybin to treat end-of-life depression and anxiety… the plaintiffs argue that DEA’s position leaves no path forward for accessing psilocybin as an end-of-life treatment. Original Article (Ganjapreneur):Federal…
…doses were made by the participants using dried [sclerotia galindoi] truffles… …did not find an effect of [sclerotia galindoi truffles] microdosing on interoceptive awareness, nor on emotion processing or symptoms of anxiety and depression… Original Article (New Atlas & Journal of Psychopharmacology): Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and…
“From our perspective, it’s really hard to see any real reason – other than individual and corporate greed – to be against home cultivation at this point,” Erik Altieri, executive director of NORML… “There’s not a lot of rational concerns when it comes to allowing a limited amount of plants for an individual to grow at…
On December 15 [2021], Freedom to Operate filed their post-grant review on a patent filed by COMPASS on what the company claims are proprietary, lab-made formulations of psilocybin. A week later, on December 22 [2021], FTO filed a second post-grant review of a second COMPASS patent. Once I saw the patent info, I sent it…
…a team of scientists from China designed a new drug they say acts in a similar fashion to… psilocybin, but without leading to hallucinations. Sheng Wang, a biochemist with the Chinese Academy of Science and a senior author of the new study,” said, “The hallucination effects definitely restrict their potential use. But now, non-hallucinogenic drugs…
Under current U.S. codes, builders, engineers, and architects must get approval to use hempcrete on a project-by-project basis, although the material is commonly used in the United Kingdom and France and has been approved for use for 30 years in Europe. The U.S. Hemp Building Foundation, the non-profit arm of the U.S. Hemp Building Association (USHBA), earlier…
Rep. Earl Blumenauer (D-OR) (on a call with former Pennsylvania Rep. Ryan Costello)… said that while he’s yet to meet with Anne Melissa Milgram [Administrator of the Drug Enforcement Administration (DEA)], he looks forward to doing so and will convey that the psilocybin case “is a golden opportunity for that agency to get in step…
Recent Comments